tiprankstipranks
Trending News
More News >

Robinhood - New Portfolio

JOSE RAMIREZ

Robinhood
Individual Investor
Ranked #96,720 out of 827,859 TipRanks' Investors
Success Rate
59%
107 out of 181
profitable transactions
Average Return
45.23%
Average return
per transaction
Share this portfolio:

Portfolio Gain

1-Month Return▲ 1.01%
6-Month Return▲ 30.69%
12-Month Return▲ 29.91%
YTD Return▲ 24.90%
Total Return▼ 2.06%

Best Trade

Opened at
Closed at-
Gain▲ 1226.67%

Bio

Compound Dividends Portfolio

Performance

18.98%0-18.98%
▲ 0.80%
▼ 0.87%
▼ 1.68%
Apr 2025
▲ 11.64%
▲ 6.28%
▲ 6.44%
May 2025
▲ 9.25%
▲ 5.14%
▲ 18.98%
Jun 2025
▲ 7.60%
▲ 2.30%
▼ 1.36%
Jul 2025
▲ 2.76%
▲ 2.05%
▲ 3.58%
Aug 2025
▲ 12.88%
▲ 3.56%
▲ 3.25%
Sep 2025
▲ 10.96%
▲ 2.38%
▲ 1.40%
Oct 2025
▼ 1.52%
▼ 0.09%
▼ 1.03%
Nov 2025
TipRanks AverageS&P 500Investor Portfolio
▲ 0.80%▼ 0.87%▼ 1.68%
▲ 11.64%▲ 6.28%▲ 6.44%
▲ 9.25%▲ 5.14%▲ 18.98%
▲ 7.60%▲ 2.30%▼ 1.36%
▲ 2.76%▲ 2.05%▲ 3.58%
▲ 12.88%▲ 3.56%▲ 3.25%
▲ 10.96%▲ 2.38%▲ 1.40%
▼ 1.52%▼ 0.09%▼ 1.03%

Recent Activity

Company Name
% of Portfolio
Return
No. of Transactions
Last Transaction
Date
Meta Platforms
0%
▼ 16.08%
1
Open
Aug 20, 2025
Alphabet Class A
1.32%
▲ 50.94%
2
Buy
Aug 04, 2025
Amazon
0%
▲ 9.51%
1
Open
Jul 22, 2025
Viracta Therapeutics
▼ 98.00%
4
Close
Jul 16, 2025
Direxion Daily S&P 500 Bull 3x Shares
22.27%
▲ 109.01%
8
Buy
Mar 29, 2025
Walt Disney
6.22%
▲ 15.68%
8
Buy
Mar 29, 2025
Coca-Cola
8.09%
▲ 23.12%
10
Buy
Mar 29, 2025
Kraft Heinz
2.79%
▼ 24.46%
12
Buy
Mar 29, 2025
Energy Transfer
9.8%
▲ 64.09%
15
Buy
Mar 29, 2025
AT&T
5.8%
▲ 54.77%
13
Buy
Mar 29, 2025
Bank of America
3.15%
▲ 69.54%
8
Buy
Mar 29, 2025
Pfizer
0.92%
▼ 7.38%
3
Buy
Mar 29, 2025
aTyr Pharma
0.96%
▼ 61.05%
8
Buy
Mar 29, 2025
Nvidia
6.11%
▲ 55.16%
3
Buy
Mar 29, 2025
Tempest Therapeutics
0.67%
▼ 20.66%
3
Buy
Mar 29, 2025
PDS Biotechnology
0.05%
▼ 10.92%
1
Open
Mar 29, 2025
Stronghold Digital Mining
▼ 97.39%
3
Close
Mar 14, 2025
Bitfarms
0.05%
▲ 203.60%
1
Open
Mar 14, 2025
Carisma Therapeutics
0.01%
▼ 98.40%
5
Buy
Oct 29, 2024
Viking Therapeutics
0.18%
▲ 699.98%
8
Sell
Oct 29, 2024